Journal Publications
-
Tzu-Li Lu, Yuh-Pyng Sher, Hui-ChenChen, Wei-ChungCheng, Ling-Heng Hsu, Chen-Chen Lee* (2022) Articulatin B chain induced dendritic cells maturation and driven type I T helper cells and cytotoxic T cells activation. Life Sciences, 302, 120635.
-
Chien-Neng Wang, Yu-Chao Lin, Bo-Chun Chang, Ching-Hsien Chen, Reen Wu, Chen-Chen Lee* (2019, Apr). Targeting the phosphorylation site of MARCKS alleviates symptoms of steroid-resistant like asthma in a murine model. British Journal of Pharmacology, 176(8):1122-1134.
-
Hung Chien-Hui, Chien-Neng Wang, Huei-Hsuan Cheng, Jiunn-Wang Liao, Yi-Ting Chen, Ya-Wen Chao, Jia Liang Jiang, Chen-Chen Lee* (2018, Oct). Baicalin Ameliorates Imiquimod-Induced Psoriasis-Like Inflammation in Mice. PLANTA MEDICA, 84(15):1110-1117.
-
Chien-Neng Wang, Yueh-Lun Lee, Yu-Pei Lin, Wen-Hui Chung, Yew-Min Tzeng, Chen-Chen Lee* (2017). Ovatodiolide suppresses allergic airway inflammation and hyperresponsiveness in a murine model of asthma. EUROPEAN JOURNAL OF PHARMACOLOGY, 812: 9-17.
-
Chen-Chen Lee, Wen-Hao Yang, Ching-Hao Li, Yu-Wen Cheng, Chi-Hao Tsai, Jaw-Jou Kang* (2016, Jul). Ligand independent aryl hydrocarbon receptor inhibits lung cancer cell invasion by degradation of Smad4. Cancer Letter, 376(2):211~217.
-
Yu-Ching Chen, Sarah Statt, Reen Wu,Hao-Teng Chang, Jiunn-Wang Liao,Chien-Neng Wang, Woei-Cherng Shyu, Chen-Chen Lee* (2016). High mobility group box 1-induced epithelial mesenchymal transition in human airway epithelial cells. Scientific Reports, 6:18815.
- Charles Robert Darwin -
“Survival of the fittest: the essence is not to adapt to the moment, but to keep pace with the times.”
PUBLICATIONS
Patent
1. PHARMACEUTICAL COMPOSITIONS CONTAINING BRAZILIN FOR INHIBITING EXPRESSION OF CYTOKINES OF T HELPER CELL TYPE II AND/OR INHIBITING EXPRESSION OF CHEMOKINES AND USES OF THE SAME Taiwan patent No. I 375671
2. Method for inhibiting production of cytokines of T helper cell type II and/or inhibiting production of chemokines using brazilin US patent No. US 8,796,327 B2
3. Suppression of allergic lung inflammation and hyperreactivity US patent No. US10314889B2

